Federated Hermes’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-472
Closed -$3K 2385
2020
Q4
$3K Buy
472
+356
+307% +$2.49K ﹤0.01% 2109
2020
Q3
$1K Buy
+116
New +$809 ﹤0.01% 2215

Other funds holding ARDS

Federated Hermes's ARDS Position: Q1 2021 in Review

Federated Hermes sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q1 2021, closing a stake of 472 shares — an estimated $3K sold.

Federated Hermes first reported a position in ARDS in Q3 2020 and held it in 2 quarters. The position peaked at $3K in Q4 2020. 12 funds tracked by Wall St. Rank hold ARDS as of Q1 2021.

  • Federated Hermes reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Federated Hermes sold 472 Aridis Pharmaceuticals Inc. Common Stock shares in Q1 2021, an estimated $3K.
  • Federated Hermes first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Federated Hermes's Aridis Pharmaceuticals Inc. Common Stock position peaked at $3K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q1 2021.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.